Literature DB >> 10086673

Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients.

H Andreassen1, E Hylander, M Rix.   

Abstract

OBJECTIVE: We conducted this study to assess bone mineral density and to evaluate conceivable predictive factors for bone loss in patients with Crohn's disease.
METHODS: One hundred-thirteen patients with Crohn's disease and 113 healthy subjects, individually matched for gender, age, and body weight were investigated. The group consisted of 68 women and 45 men. The median duration of Crohn's disease was 6 yr. Two-thirds of the patients had been subjected to intestinal resection. Seventy-seven percent had at some time been treated with corticosteroids. Bone mineral density in the lumbar spine, the hip, and the total body skeleton was measured by dual-energy X-ray absorptiometry (DEXA).
RESULTS: In patients with Crohn's disease bone mineral density was not different from that of healthy controls except for a regional decrease in bone mineral density of the hip in female patients. The strongest predictors of bone mineral density were gender, age, and body weight. Corticosteroid use was only a weak predictor of diminished bone density. Duration of disease and intestinal resection had no predictive value for bone mineral density.
CONCLUSIONS: Gender, age, and body weight are the major determinants of bone mineral density in patients with Crohn's disease. As in healthy individuals, the combined effect of these factors account for up to 50% of the variability in bone mineral density.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086673     DOI: 10.1111/j.1572-0241.1999.00866.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Longitudinal study of bone mineral density in patients with Crohn's disease.

Authors:  D J de Jong; L Mannaerts; L G M van Rossum; F H M Corstens; A H J Naber
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

2.  Ileum resection is the most predictive factor for osteoporosis in patients with Crohn's disease.

Authors:  R A van Hogezand; D Bänffer; A H Zwinderman; E V McCloskey; G Griffioen; N A T Hamdy
Journal:  Osteoporos Int       Date:  2006-01-04       Impact factor: 4.507

3.  Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.

Authors:  Sarah A Bartram; Robert T Peaston; David J Rawlings; David Walshaw; Roger M Francis; Nick P Thompson
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

4.  Sex-Specific Issues in Inflammatory Bowel Disease.

Authors:  Elizabeth Rosenblatt; Sunanda Kane
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-09

5.  Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease.

Authors:  C E Todhunter; A Sutherland-Craggs; S A Bartram; P T Donaldson; A K Daly; R M Francis; J C Mansfield; N P Thompson
Journal:  Gut       Date:  2005-07-11       Impact factor: 23.059

Review 6.  Nutritional management of adults with inflammatory bowel disease: practical lessons from the available evidence.

Authors:  Melissa A Smith; Trevor Smith; Timothy M Trebble
Journal:  Frontline Gastroenterol       Date:  2012-05-21

Review 7.  Glucocorticoid-induced osteoporosis in men.

Authors:  R A Adler; M C Hochberg
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

8.  Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease.

Authors:  Letícia Helena Caldas Lopes; Vera Lucia Sdepanian; Vera Lúcia Szejnfeld; Mauro Batista de Morais; Ulysses Fagundes-Neto
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

Review 9.  Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Authors:  Lorena Rodríguez-Bores; Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

10.  Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients.

Authors:  Marina Mauro; Vladimir Radovic; David Armstrong
Journal:  Can J Gastroenterol       Date:  2007-10       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.